198 related articles for article (PubMed ID: 38836231)
1. Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.
Karabaeva RZ; Vochshenkova TA; Mussin NM; Albayev RK; Kaliyev AA; Tamadon A
Front Endocrinol (Lausanne); 2024; 15():1365738. PubMed ID: 38836231
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification: a regulatory mechanism in essential hypertension.
Arif M; Sadayappan S; Becker RC; Martin LJ; Urbina EM
Hypertens Res; 2019 Aug; 42(8):1099-1113. PubMed ID: 30867575
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms in coronary artery disease: The current state and prospects.
Duan L; Liu C; Hu J; Liu Y; Wang J; Chen G; Li Z; Chen H
Trends Cardiovasc Med; 2018 Jul; 28(5):311-319. PubMed ID: 29366539
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of methylation modifications in diabetic cardiomyopathy.
Hao J; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
[TBL] [Abstract][Full Text] [Related]
6. Hypertensive epigenetics: from DNA methylation to microRNAs.
Wang J; Gong L; Tan Y; Hui R; Wang Y
J Hum Hypertens; 2015 Oct; 29(10):575-82. PubMed ID: 25631220
[TBL] [Abstract][Full Text] [Related]
7. Programming of Essential Hypertension: What Pediatric Cardiologists Need to Know.
Morgado J; Sanches B; Anjos R; Coelho C
Pediatr Cardiol; 2015 Oct; 36(7):1327-37. PubMed ID: 26015087
[TBL] [Abstract][Full Text] [Related]
8. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modifications in Essential Hypertension.
Wise IA; Charchar FJ
Int J Mol Sci; 2016 Mar; 17(4):451. PubMed ID: 27023534
[TBL] [Abstract][Full Text] [Related]
10. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and arterial hypertension: the challenge of emerging evidence.
Friso S; Carvajal CA; Fardella CE; Olivieri O
Transl Res; 2015 Jan; 165(1):154-65. PubMed ID: 25035152
[TBL] [Abstract][Full Text] [Related]
12. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular epigenetics: from DNA methylation to microRNAs.
Udali S; Guarini P; Moruzzi S; Choi SW; Friso S
Mol Aspects Med; 2013; 34(4):883-901. PubMed ID: 22981780
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modification and therapeutic targets of diabetes mellitus.
Singh R; Chandel S; Dey D; Ghosh A; Roy S; Ravichandiran V; Ghosh D
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32815547
[TBL] [Abstract][Full Text] [Related]
16. Interplay between microRNAs and the epigenetic machinery: an intricate network.
Iorio MV; Piovan C; Croce CM
Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
[TBL] [Abstract][Full Text] [Related]
17. Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease.
Shen Y; Dai Y; Wang XQ; Zhang RY; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2019 Nov; 18(1):160. PubMed ID: 31733658
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Modification in Coronary Atherosclerosis: JACC Review Topic of the Week.
Rizzacasa B; Amati F; Romeo F; Novelli G; Mehta JL
J Am Coll Cardiol; 2019 Sep; 74(10):1352-1365. PubMed ID: 31488273
[TBL] [Abstract][Full Text] [Related]
19. ncRNAs and polyphenols: new therapeutic strategies for hypertension.
Shirazi-Tehrani E; Chamasemani A; Firouzabadi N; Mousaei M
RNA Biol; 2022; 19(1):575-587. PubMed ID: 35438046
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics Variation and Pathogenesis in Diabetes.
Zhang H; Pollin TI
Curr Diab Rep; 2018 Oct; 18(11):121. PubMed ID: 30280270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
